Navigation Links
Medarex and Massachusetts Biologic Laboratories Announce Primary Objective Achieved in Phase 2 Trial of Monoclonal Antibody Combination for the Treatment of Clostridium difficile Associated Diarrhea (CDAD)
Date:11/3/2008

xchange Commission (SEC), including its Annual Report on Form 10-K for the fiscal year ended December 31, 2007 and its quarterly reports on Form 10-Q. There can be no assurance that such development efforts will succeed or that developed products will receive required regulatory clearance or that, even if such regulatory clearance were received, such products would ultimately achieve commercial success. Copies of Medarex's public disclosure filings are available from its investor relations department.

Medarex(R), the Medarex logo, UltiMAb(R) and HuMAb(TM) are trademarks of Medarex, Inc. All rights are reserved.

(1) Redelings MD et al. "Increase in Clostridium difficile-related mortality rates, United States, 1999-2004." Emerging Infectious Diseases. 2007; 13(9):1417-1419.

(2) "Current Trends: Is the Epidemic Ongoing?" presentation (#3635) by LC McDonald at 2008 ICAAC/IDSA.

(3) McDonald, LC et al. "An epidemic, toxin gene-variant strain of Clostridium difficile." The New England Journal of Medicine. 2005; 353(23):2433-2441.

(4) Kelly CP et al. "Clostridium difficile: more difficult than ever." The New England Journal of Medicine. 2008; 3359(18):1932-1940.

(5) Sunenshine RH et al. "Clostridium difficile-associated disease: new challenges form an established pathogen." Cleveland Clinic Journal of Medicine. 2006; 73(2):187-197.


'/>"/>
SOURCE Medarex, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Medarex Announces 2008 Third Quarter Financial Results
2. Medarex And PharmAthene Announce New Therapeutic Data for Anthrax Anti-Toxin, Valortim(R)
3. Medarex to Present at the UBS Global Life Sciences Conference
4. Medarex to Present at the Thomas Weisel Partners Healthcare Conference
5. BioWa and Medarex Announce License of BioWas COMPLEGENT(TM) Technology
6. Medarex Announces July 10 Live Webcast of R&D Day Event
7. Medarex to Present at the Jefferies Second Annual Healthcare Conference
8. Medarex to Present at the 29th Annual Goldman Sachs Healthcare Conference
9. Medarex to Present at the Bank of America 2008 Healthcare Conference
10. Medarex to Present at the Morgan Stanley Global Healthcare Unplugged Conference
11. Medarex Reports Phase 1/2 Clinical Data of MDX-060 in Lymphoma at American Association for Cancer Research Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... 23, 2015 Biofertilizers stimulate microbial activities ... nitrogen and phosphorous through the activities in the soil ... increasing due to the stress on reducing environmental pollution ... The report defines and segments the bio fertilizers market ...
(Date:1/22/2015)... 22, 2015  Transwestern | RBJ today announces the firm brokered ... for Shire a leading biopharmaceutical company, at Two Ledgemont Center ... Robert Richards , president, and Brian Cohen , ... entire five-floor building at 95 Hayden Ave. Photo ...
(Date:1/22/2015)... Protocol Networks brings independent technology consulting to the ... consultants, Protocol Networks has recently announced its expansion into ... his company has attracted several clients in The Constitution ... as others. With the success of these engagements, Rogers ...
(Date:1/22/2015)... 22, 2015 Controlled Substance Compliance Services ... helps companies check the legal requirements around using controlled ... China. , As their international operations expand and ... software solutions built as a result of the first ...
Breaking Biology Technology:Biofertilizers Market Expected to Reach $1,649.7 Million by 2019 - New Report By MarketsandMarkets 2Biofertilizers Market Expected to Reach $1,649.7 Million by 2019 - New Report By MarketsandMarkets 3Biofertilizers Market Expected to Reach $1,649.7 Million by 2019 - New Report By MarketsandMarkets 4Transwestern | RBJ Advises Shire in 202,000 SF Lease, Creating Boston's Largest Suburban Biotech Campus 2Protocol Networks Brings Independent Technology Consulting to the Constitution State 2Global Compliance Service for Controlled Substances to Expand to China 2
... Biotechnology Company Adopts Pharsight,s Groundbreaking ... Automation Software, ... a leading provider of software and strategic,services for optimizing clinical drug ... WinNonlin AutoPilot.,This sale marks Pharsight,s third new customer win since the ...
... /PRNewswire-FirstCall/ - GeneNews Limited (TSX: GEN),a company ... for the early detection of diseases and ... started collecting patient samples,for clinical validation studies ... In June 2006, GeneNews presented training set ...
... 17 /PRNewswire-FirstCall/ - Helix BioPharma Corp.,(TSX, FSE: "HBP") ... purchase, by way of private placement, of a ... for gross proceeds totaling CDN$16,867,200.,Proceeds from the placement ... the Company,s research and development initiatives., The ...
Cached Biology Technology:Pharsight Signs Third WinNonlin(R) AutoPilot(TM) Customer 2Pharsight Signs Third WinNonlin(R) AutoPilot(TM) Customer 3GeneNews initiates patient sample accrual for validation studies of colon cancer blood test 2GeneNews initiates patient sample accrual for validation studies of colon cancer blood test 3Helix BioPharma announces $16.9 million private placement of common shares 2
(Date:1/22/2015)... Research and Markets ( http://www.researchandmarkets.com/research/wxdglm/global_wearable ) ... Wearable Technologies Market and Applications, Opportunities, Industry Analysis, ... 2014-2020" report to their offering. , ... can be worn on the user,s body and ...
(Date:12/22/2014)... SHELTON, Conn. , Dec. 22, 2014  NXT-ID, Inc. (NASDAQ: ... a biometric authentication company focused on the growing mobile commerce ... consultant, Apollo Robbins for the 2015 International CES ... Apollo Robbins will be at the NXT-ID booth ...
(Date:12/19/2014)... and Markets ( http://www.researchandmarkets.com/research/86ncd6/micro_market ) has announced the ... Security Systems Market" report to their offering. ... perimeter security market is estimated to grow at a CAGR ... holds a larger share in this market, Canada ...
Breaking Biology News(10 mins):Global Wearable Technologies Market and Applications, Opportunities, Industry Analysis, Segmentation, Size, Growth, Share, Overview, Trends and Forecast 2014-2020 2NXT-ID Hires Master Pickpocket and Security Consultant Apollo Robbins for Wocket Smart Wallet CES 2015 Debut 2NXT-ID Hires Master Pickpocket and Security Consultant Apollo Robbins for Wocket Smart Wallet CES 2015 Debut 3NXT-ID Hires Master Pickpocket and Security Consultant Apollo Robbins for Wocket Smart Wallet CES 2015 Debut 4Micro Market Monitor: North America Perimeter Security Systems Market (Intrusion Detection Sensor, Video Surveillance, Communication/Alarm and Notification, Access Control System) 2Micro Market Monitor: North America Perimeter Security Systems Market (Intrusion Detection Sensor, Video Surveillance, Communication/Alarm and Notification, Access Control System) 3
... And, at least for mice, it's one that is best made ... designed help scientists understand the brain chemicals that guide mate selection, ... a male mouse alone or a male mouse with a female. ... females. , "Our data suggest that female mice may use, or ...
... Infectious Diseases (NIAID), part of the National Institutes ... a large international HIV/AIDS trial comparing continuous antiretroviral ... of CD4+ cells has been stopped. Enrollment was ... twice the risk of disease progression (the development ...
... Texas M. D. Anderson Cancer Center have created a ... to find, highlight, and deliver genes to tumors in ... journal Cell, is potentially an important step in making ... it may also allow prediction and monitoring of how ...
Cached Biology News:When mice choose mates, experience counts 2International HIV/AIDS trial finds continuous antiretroviral therapy superior to episodic therapy 2International HIV/AIDS trial finds continuous antiretroviral therapy superior to episodic therapy 3International HIV/AIDS trial finds continuous antiretroviral therapy superior to episodic therapy 4New hybrid virus provides targeted molecular imaging of cancer 2
Agarose, pulse field, 100 g. Nuclease-free.Gel point (1.5%): 36 1.5 C, EEO (-mr): 1800 g/cm2. Category: Nucleotides & Enzymes & Biochemicals, Ultrapure Biochemicals ....
Molecular Biological Resources has extensive abilities cloning and expression of prokaryotic and eukaryotic proteins. Please contact lloconne@molbiores.com to discuss your project. Contact lloconne@...
Bethyl Laboratories packages antibodies, conjugates and calibrators to provide quantitative ELISA kits. Each kit contains the following components, sufficient for 1000 single well assays....
quantitation of phosphatase activity, evaluation of hits and leads from HTS...
Biology Products: